Stigmasterol regulates microglial M1 / M2 polarization via the TLR4 / NF‐κB pathway to alleviate neuropathic pain
Phytotherapy Research · 2024-01 · 38 (1) · 265-279
DOI: 10.1002/ptr.8039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 23.10.2023. Verfasst von Waimei Si und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: NF-kappa B, Neuralgia. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Research Foundation of China.
Abstract (Originalsprache)
(Switching from the microglial M1 phenotype to the M2 phenotype is a promising therapeutic strategy for neuropathic pain (NP). This study aimed to investigate the potential use of stigmasterol for treating NP. In animal experiments, 32 male Sprague–Dawley rats were randomly divided into the sham operation group, chronic constriction injury (CCI) group, CCI + ibuprofen group, and CCI + stigmasterol group. We performed behavioral tests, enzyme‐linked immunosorbent assay, hematoxylin‐esoin staining (H&E) staining and immunohistochemistry, immunofluorescence, and Western blotting. In cell experiments, we performed flow cytometry, immunofluorescence, Western blotting, and qRT‐PCR. Stigmasterol reduced thermal and mechanical hyperalgesia and serum IL‐1β and IL‐8 levels and increased serum IL‐4 and TGF‐β levels in CCI rats. Stigmasterol reduced IL‐1β, COX‐2, and TLR4 expression in the right sciatic nerve and IL‐1β expression in the spinal cord. Stigmasterol reduced the expression of Iba‐1, TLR4, MyD88, pNF‐κB, pP38 MAPK, pJNK, pERK, COX‐2, IL‐1β, and CD32 in the spinal cord of CCI rats while increasing the expression of IL‐10 and CD206. Stigmasterol decreased M1 polarization markers and increased M2 polarization markers in lipopolysaccharide (LPS)‐induced microglia and decreased the expression of Iba‐1, TLR4, MyD88, pNF‐κB, pP38 MAPK, pJNK, pERK, iNOS, COX‐2, and IL‐1β in LPS‐treated microglia while increasing the expression of Arg‐1 and IL‐10. Stigmasterol regulates microglial M1/M2 polarization via the TLR4/NF‐κB pathway to alleviate NP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
ORCID-Profile: Waimei Si, Xin Li, Bei Jing, Shiquan Chang, Zhenni Chen, Guoping Zhao, Di Zhang
Förderung
- National Natural Science Foundation of China
- Postdoctoral Research Foundation of China
Zitieren
APA
Si, W., Li, X., Jing, B., Chang, S., Zheng, Y., Chen, Z., Zhao, G., & Zhang, D. (2024). Stigmasterol regulates microglial M1 / M2 polarization via the TLR4 / NF‐κB pathway to alleviate neuropathic pain. Phytotherapy Research, 38(1), 265-279. https://doi.org/10.1002/ptr.8039
Vancouver
Si W, Li X, Jing B, Chang S, Zheng Y, Chen Z, et al. Stigmasterol regulates microglial M1 / M2 polarization via the TLR4 / NF‐κB pathway to alleviate neuropathic pain. Phytotherapy Research. 2024;38(1):265-279. doi:10.1002/ptr.8039
BibTeX
@article{Si2024,
author = {Si, Waimei and Li, Xin and Jing, Bei and Chang, Shiquan and Zheng, Yachun and Chen, Zhenni and Zhao, Guoping and Zhang, Di},
title = {Stigmasterol regulates microglial M1 / M2 polarization via the TLR4 / NF‐κB pathway to alleviate neuropathic pain},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {1},
pages = {265--279},
doi = {10.1002/ptr.8039}
}
EUVIMED